Cellular and Biophysical Pipeline for the Screening of Peroxisome Proliferator-Activated Receptor Beta/Delta Agonists: Avoiding False Positives

Peroxisome proliferator-activated receptor beta/delta (PPARß/δ) is considered a therapeutic target for metabolic disorders, cancer, and cardiovascular diseases. Here, we developed one pipeline for the screening of PPARß/δ agonists, which reduces the cost, time, and false-positive hits. The first ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Videira, Natália Bernardi, Batista, Fernanda Aparecida Heleno, Torres Cordeiro, Artur, Figueira, Ana Carolina Migliorini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924986/
https://www.ncbi.nlm.nih.gov/pubmed/29849537
http://dx.doi.org/10.1155/2018/3681590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924986/
https://www.ncbi.nlm.nih.gov/pubmed/29849537
http://dx.doi.org/10.1155/2018/3681590

Ejemplares similares